EPIRUS Biopharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$48.9M

576 transactions

Summary

EPIRUS Biopharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $8.1MSales: $39.6M66 insiders

Date	Insider	Type	Value
2016-02-27	Munshi Amit(Chief Executive Officer)	F	$12K
2016-02-27	Shea Thomas A.(Chief Financial Officer)	F	$4K
2016-02-27	Wyand Michael(Chief Technical Officer)	F	$4K
2016-05-27	Ticktin Robert(General Counsel)	A	$0
2016-05-27	Aurentz Vincent(Chief Business Officer)	A	$0
2016-05-27	Wyand Michael(President and COO)	A	$0
2016-05-27	Shea Thomas A.(Chief Financial Officer)	A	$0
2016-02-27	Wyand Michael(Chief Technical Officer)	M	$0
2016-02-27	Wyand Michael(Chief Technical Officer)	M	$0
2016-02-27	Wyand Michael(Chief Technical Officer)	M	—
2016-02-27	Wyand Michael(Chief Technical Officer)	M	—
2016-02-27	Munshi Amit(Chief Executive Officer)	M	$0
2016-02-27	Munshi Amit(Chief Executive Officer)	M	$0
2016-02-27	Munshi Amit(Chief Executive Officer)	M	—
2016-02-27	Munshi Amit(Chief Executive Officer)	M	—
2016-02-27	Shea Thomas A.(Chief Financial Officer)	M	$0
2016-02-27	Shea Thomas A.(Chief Financial Officer)	M	$0
2016-02-27	Shea Thomas A.(Chief Financial Officer)	M	—
2016-02-27	Shea Thomas A.(Chief Financial Officer)	M	—
2016-02-27	Ticktin Robert(General Counsel)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

EPIRUS Biopharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope